Transitioning from Heparin to Apixaban After Total Hip Arthroplasty
Yes, it is safe to start apixaban after stopping heparin prophylaxis following total hip arthroplasty, with careful attention to timing to avoid overlapping anticoagulation.
Timing of Transition
The key principle is to avoid overlapping the two anticoagulants. 1
- Wait 12 hours after the last prophylactic-dose heparin (LMWH or UFH) before starting apixaban 1
- This timing allows adequate clearance of heparin while maintaining continuous VTE prophylaxis 1
Apixaban Dosing for Hip Arthroplasty
For VTE prophylaxis after total hip replacement, apixaban should be dosed at 2.5 mg twice daily 1, 2, 1, 3
- Duration: Continue for 5 weeks (32-38 days) after total hip arthroplasty 1
- Initial dose timing: If starting fresh (not transitioning from heparin), begin 12-24 hours after surgery 2
Important Safety Considerations
Surgical Hemostasis Must Be Established
- Only start apixaban once adequate surgical hemostasis has been achieved 1
- Typically, therapeutic-dose anticoagulation can be started 24-72 hours postoperatively, but prophylactic doses (like 2.5 mg twice daily) can begin earlier 1
Epidural Catheter Considerations
If an epidural catheter is still in place, do NOT start apixaban 1
- Continue heparin until the epidural catheter can be safely removed 1
- Only transition to apixaban after catheter removal with appropriate timing intervals 1
Renal Function Monitoring
Check creatinine clearance before starting apixaban, especially if surgery or the patient's medical condition could affect renal function 1
- Apixaban dose adjustments may be needed based on renal function 1
- For prophylaxis after hip arthroplasty, standard dosing is 2.5 mg twice daily regardless of age or mild renal impairment 1
Clinical Evidence Supporting This Approach
The French Working Group on Perioperative Hemostasis explicitly addresses this transition, stating that direct oral anticoagulants (DOAs) at prophylactic doses can be prescribed for hip or knee arthroplasties "with care to avoid overlapping the change in molecules" 1. The 12-hour interval between last heparin dose and first apixaban dose is specifically recommended 1.
Apixaban has demonstrated superior efficacy compared to enoxaparin in the ADVANCE-3 trial for hip arthroplasty patients, with lower rates of VTE (1.4% vs 3.9%) and similar or lower bleeding rates 2, 4. The drug is FDA-approved for this indication 3.
Common Pitfalls to Avoid
- Do not overlap heparin and apixaban - this increases bleeding risk without additional benefit 1
- Do not start apixaban if epidural catheter is in place - risk of spinal/epidural hematoma 1, 3
- Do not use therapeutic doses (10 mg twice daily) for prophylaxis - the prophylactic dose is 2.5 mg twice daily 1, 3